Prevalence and Predictors of Distal Limb Ischemia in Minimally Invasive Cardiac Surgery.
1 other identifier
observational
280
1 country
1
Brief Summary
Peripheral arterial cannulation is a necessity for installation of cardiopulmonary bypass in minimally invasive cardiac surgery (MICS). In the vast majority of cases, the femoral artery is the preferred arterial cannulation site. Distal limb hypoperfusion and ischemia can occur in the cannulated limb since antegrade perfusion is not routinely provided. Furthermore, the diameter of the cannula required to maintain adequate cardiopulmonary bypass (CPB) flow is often approaching that of the patient's femoral artery diameter, compromising distal blood flow. The possibility of distal limb ischemia is often raised as a criticism to peripheral cannulation for cardiopulmonary bypass and by extent to minimally invasive cardiac surgery. Ischemia of the lower limb is of high incidence in patients undergoing extracorporeal membrane oxygenation (ECMO) therapy, in which the same femoral cannulation technique is used. Therefore this complication has extensively been described in ECMO literature. However, no clinical trials have been performed in patients undergoing MICS, despite the same cannulation and perfusion route. ECMO patients often differ from MICS patients in morbidity as well as in duration of cannulation. Up to now, one could not observe any clinical sequelae of limb ischemia in MICS patients but a formal study of distal leg perfusion in MICS is recommended to screen its safety and to identify possible risk factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 2, 2019
CompletedFirst Posted
Study publicly available on registry
September 9, 2019
CompletedStudy Start
First participant enrolled
November 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 27, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 27, 2021
CompletedJune 7, 2022
June 1, 2022
1.2 years
September 2, 2019
June 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Drop of 15% in regional oxygen saturation (rSO2) lasting 4 minutes or longer between the cannulated and non-cannulated limb
A drop of 15% or more in StO2 for ≥ 4 minutes between the cannulated and non-cannulated leg during the cannulation period
Duration of the surgery
Secondary Outcomes (4)
Difference in tissue oxygenation index (TOI) compared to baseline
Duration of the surgery
Identification of predictors of poor distal perfusion in the cannulated limb
from surgery until 6 months after surgery
Peripheral vascular surgery
6 months after surgery
Relationship between distal limb ischemia and acute kidney injury
through study completion, an average of 6 months
Study Arms (1)
Minimally invasive cardiac surgery
All consecutive patients presenting for minimally invasive cardiac surgery will be screened for participation to the study.
Interventions
On arrival in the operating room, oximeter pads of a NIRO-200NX (NIRO,Hamamatsu® , Japan) NIRS monitor will be placed on the muscles of the calf bilaterally. Lower extremity NIRS is an added monitoring tool as it is currently not being used in our institutional clinical management. Neither anesthetic nor surgical plans will be altered by the study and are left to the discretion of the attending consultant. Also, perfusion goals may not be altered to the results of the leg NIRS. Therefore, the NIRS display will be covered in the operating room throughout the surgery.
Eligibility Criteria
All consecutive patients presenting for minimally invasive cardiac surgery will be screened for participation to the study. Eligible participants fulfill all inclusion criteria and no exclusion criteria.
You may qualify if:
- \. Patients undergoing minimally invasive cardiac surgery older than 18 years.
You may not qualify if:
- History of leg amputation.
- Calf muscle atrophy due to neuromuscular disorder or muscle diseases.
- Stanford type A aortic dissection.
- BMI \> 40.
- Allergy for NIRS electrode.
- Revision surgery \< 72h after primary surgery.
- Postoperative need for intra-aortic balloon pump and/or ECMO.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jessa Hospitallead
Study Sites (1)
Department of Anesthesiology and Intensive Care
Hasselt, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Anesthesiologist, MD, PhD
Study Record Dates
First Submitted
September 2, 2019
First Posted
September 9, 2019
Study Start
November 25, 2019
Primary Completion
January 27, 2021
Study Completion
June 27, 2021
Last Updated
June 7, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share